GSE202843
MeRIP-seq
As the most prevalent chemical modifications on eukaryotic mRNAs, N6-methyladenosine (m6A) methylation was reported to participate in the regulation of various metabolic diseases. In order to investigate the roles of m6A methylation in non-alcoholic fatty liver disease (NAFLD). The high-throughput sequencing was performed to identify the m6A methylation patterns in HFD mice. Overall design: MeRIP-seq for 6 samples.